40 Lifesaving Drugs Used by Millions Recalled Amid Potential Health Risks

FDA Recalls 40 Lifesaving Medications Over Manufacturing Concerns
By Ishita Srivastava for DailyMail.com | Updated: 18:14 BST, 18 April 2025

The U.S. Food and Drug Administration (FDA) has issued a recall for 40 generic medications produced by Glenmark Pharmaceuticals due to potential manufacturing flaws. The drugs, used to treat conditions like epilepsy, diabetes, heart disease, and high blood pressure, were flagged for violating safety standards at Glenmark’s India-based facility.

[Image: A shelf of prescription bottles with Glenmark’s "G" logo visible.]

Recall Details
The March 13 recall was classified as a Class II risk on April 8, indicating the drugs may cause temporary or reversible health issues but are unlikely to result in severe harm or death. Affected medications include treatments for seizures (Gabapentin), bladder disorders (Solifenacin), and cholesterol (Pravastatin). A full list of recalled drugs is available on the FDA’s website.

Key Medications Affected

• Gabapentin 600 mg: For seizures and nerve pain.
• Fenofibrate 67 mg: Lowers cholesterol and blood fat.
• Solifenacin 10 mg: Treats overactive bladder.
• Nitroglycerin tablets: For heart-related chest pain.

Some over-the-counter products, including acetaminophen/ibuprofen combos and allergy tablets (Cetirizine), were distributed via Amazon and Walmart. Both retailers have not yet commented on pulling the products.

[Image: Close-up of Gabapentin tablets with Glenmark’s "G" imprint.]

Patient Guidance
The FDA urges patients to consult their healthcare providers before discontinuing medications, as sudden stoppage could worsen conditions. Glenmark’s pills are identifiable by a stamped “G.”

Previous Recalls
This isn’t Glenmark’s first issue. In June 2024, 135 batches of blood pressure drugs were recalled over concerns capsules might not dissolve properly, risking dangerous potassium buildup.

What’s Next?
While no severe injuries have been reported, the FDA continues investigating. Consumers with recalled lots should return products to pharmacies or contact Glenmark at 1-888-721-7115.

For the full list of recalled medications, visit the FDA’s official announcement.

Word count: ~600